BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 140 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $0 | – | 50 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 50 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 50 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | – | 50 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | – | 50 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | -100.0% | 50 | -80.0% | 0.00% | – |
| Q2 2018 | $1,000 | 0.0% | 250 | 0.0% | 0.00% | – |
| Q1 2018 | $1,000 | -50.0% | 250 | -44.4% | 0.00% | – |
| Q4 2017 | $2,000 | -66.7% | 450 | -55.0% | 0.00% | – |
| Q4 2016 | $6,000 | -33.3% | 1,000 | -50.0% | 0.00% | – |
| Q3 2016 | $9,000 | +80.0% | 2,000 | 0.0% | 0.00% | – |
| Q2 2016 | $5,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 1,105,673 | $8,237,000 | 6.28% |
| Sarissa Capital Management LP | 8,175,000 | $60,903,000 | 6.22% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,980,870 | $22,207,000 | 2.78% |
| DG Capital Management, LLC | 1,075,732 | $8,014,000 | 1.70% |
| Ghost Tree Capital, LLC | 900,000 | $6,705,000 | 1.49% |
| Parkman Healthcare Partners LLC | 538,370 | $4,011,000 | 1.03% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,835,810 | $43,477,000 | 0.86% |
| Formidable Asset Management, LLC | 470,419 | $3,470,000 | 0.80% |
| KNOTT DAVID M | 219,461 | $1,635,000 | 0.74% |
| Altium Capital Management LP | 250,000 | $1,863,000 | 0.70% |